Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 13, Issue 10, Pages 1253-1264
Publisher
Informa UK Limited
Online
2014-09-25
DOI
10.1586/14760584.2014.936391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome
- (2014) M. Kool et al. JOURNAL OF IMMUNOLOGY
- Pertussis: A Persistent Cause of Morbidity and Mortality in Young Infants
- (2014) Joseph B. Cantey et al. JOURNAL OF PEDIATRICS
- A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers
- (2014) Rigmor Thorstensson et al. PLoS One
- Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007
- (2013) Hans Hallander et al. Clinical and Vaccine Immunology
- Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review
- (2013) G Amirthalingam et al. Eurosurveillance
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic cells and other innate determinants of T helper cell polarisation
- (2013) Kevin P. Walsh et al. TRENDS IN IMMUNOLOGY
- Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
- (2013) Pádraig J. Ross et al. PLoS Pathogens
- Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro
- (2012) Tirth R. Ghimire et al. IMMUNOLOGY LETTERS
- Newly Emerging Clones of Bordetella pertussis Carrying prn2 and ptxP3 Alleles Implicated in Australian Pertussis Epidemic in 2008–2010
- (2012) Sophie Octavia et al. JOURNAL OF INFECTIOUS DISEASES
- California Pertussis Epidemic, 2010
- (2012) Kathleen Winter et al. JOURNAL OF PEDIATRICS
- Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates
- (2012) J M Warfel et al. Mucosal Immunology
- Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease
- (2012) James D. Cherry NEW ENGLAND JOURNAL OF MEDICINE
- Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
- (2012) Nicola P. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Escherichia coli Heat-Labile Enterotoxin Promotes Protective Th17 Responses against Infection by Driving Innate IL-1 and IL-23 Production
- (2011) C. F. Brereton et al. JOURNAL OF IMMUNOLOGY
- Challenges in infant immunity: implications for responses to infection and vaccines
- (2011) Mercy PrabhuDas et al. NATURE IMMUNOLOGY
- Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis
- (2011) Srinivas Garlapati et al. VACCINE
- The role of Th17 cytokines in primary mucosal immunity
- (2010) Jay K. Kolls et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Intracellular Trafficking of Bordetella pertussis in Human Macrophages
- (2010) Y. A. Lamberti et al. INFECTION AND IMMUNITY
- Global, regional, and national causes of child mortality in 2008: a systematic analysis
- (2010) Robert E Black et al. LANCET
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis
- (2010) Pascal Feunou Feunou et al. PLoS One
- Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens
- (2010) Doo-Hee Shim et al. VACCINE
- Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1
- (2010) Pascal Feunou Feunou et al. VACCINE
- Bordetella pertussisand Pertussis Vaccines
- (2009) Nicole Guiso CLINICAL INFECTIOUS DISEASES
- Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
- (2009) David J. M. Lewis et al. PLoS One
- Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice
- (2009) Charlotte Andreasen et al. PLoS One
- A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity
- (2009) Jason Kindrachuk et al. VACCINE
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model
- (2008) Nico Marr et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now